Table II.

Prognostic value of TFAP4 expression regarding overall survival in the Cancer Genome Atlas dataset.

	Univariate analysis		Multivariate analysis
Variable	HR (95% CI)	P-value	HR (95% CI)	P-value
Clinical stage (III/IV vs. I/II)	1.809 (0.735–4.453)	0.197	1.027 (0.081–13.006)	0.984
N stage (N1/2 vs. N0)	1.633 (0.674–3.956)	0.278	0.824 (0.089–7.613)	0.865
M stage (M1 vs. M0)	2.706 (1.023–7.162)	0.045	1.890 (0.457–7.813)	0.379
Vascular invasion (yes vs. no)	5.089 (1.704–15.197)	0.004	2.990 (0.986–9.064)	0.053
TFAP4 expression (high vs. low)	3.332 (1.245–8.923)	0.017	8.200 (1.838–36.591)	0.006

HR, hazard ratio; CI, confidence interval; TFAP4, transcription factor activating enhancer binding protein 4.